Chief Medical Officer, Denver, CO.
JPS Health Network, Fort Worth, TX.
Adv Chronic Kidney Dis. 2022 Jan;29(1):40-44. doi: 10.1053/j.ackd.2022.02.008.
Three years ago, the Advancing American Kidney Health executive order launched a substantial effort with the goals of delaying the progression of kidney disease while also increasing kidney transplantation and the utilization of home dialysis. Included among the initiatives created by this executive order are two new payment models under the supervision of the Centers for Medicare & Medicaid Services Innovation Center. The End Stage Renal Disease Treatment Choices model is a mandatory payment model impacting nephrologists and dialysis providers in many regions across the country. The Kidney Care Choices model offers nephrologists four voluntary options for participation in value-based care. The early experience of two large kidney care organizations highlights the improvements these payment models have demonstrated over prior kidney care payment models while also suggesting additional opportunities for improvement. These models offer nephrologists the opportunity to partner with other providers and deliver patient-centered care across the kidney care continuum. The models represent another step toward value-based care and, if successful, should yield great benefits for patients with kidney disease.
三年前，《推进美国肾脏健康行政命令》（Advancing American Kidney Health Executive Order）发布，目标是延缓肾脏病的进展，同时增加肾脏移植和家庭透析的应用。该行政命令创建的举措中包括两个新的支付模式，由医疗保险和医疗补助服务中心创新中心监管。终末期肾病治疗选择模型是一个强制性的支付模式，影响着全美许多地区的肾脏病医生和透析提供商。肾脏护理选择模型为肾脏病医生提供了四种参与基于价值的护理的自愿选择。两个大型肾脏护理组织的早期经验突出了这些支付模式相对于以前的肾脏护理支付模式所表现出的改进，同时也提出了进一步改进的机会。这些模式为肾脏病医生提供了与其他提供者合作的机会，并在整个肾脏护理连续体中提供以患者为中心的护理。这些模式代表了迈向基于价值的护理的又一步，如果成功，应该会给肾脏病患者带来巨大的益处。
